Pacific Biosciences
PACB
PACB
98 hedge funds and large institutions have $430M invested in Pacific Biosciences in 2017 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 42 increasing their positions, 19 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 107 → 98 (-9)
36% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 22
87% less call options, than puts
Call options by funds: $260K | Put options by funds: $1.95M
Holders
98
Holding in Top 10
3
Calls
$260K
Puts
$1.95M
Top Buyers
| 1 | +$16.1M | |
| 2 | +$9.01M | |
| 3 | +$5.25M | |
| 4 |
SFM
Soros Fund Management
New York
|
+$3.52M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.15M |
Top Sellers
| 1 | -$5.87M | |
| 2 | -$4.42M | |
| 3 | -$3.73M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.15M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.14M |